GIT Flashcards

1
Q

T/F: Nausea and vomiting may be manifestation of a wide
variety of condition including adverse effects from
medication; systemic disorder or infections; pregnancy;
vestibular dysfunction; CNS infection or increased
pressure

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SEROTONIN 5-HT3 ANTAGONISTs

A

Ondansetron, Granisetron, Dolasetron, Palonosteron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Potent antiemetic properties that are mediated in part
through central 5-HT3 receptor

A

SEROTONIN 5-HT3 ANTAGONIST (Ondansetron, Granisetron, Dolasetron, Palonosteron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F:SEROTONIN 5-HT3 ANTAGONIST (Ondansetron, Granisetron, Dolasetron, Palonosteron) may be used in cancer chemotherapy

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SEROTONIN 5-HT3 ANTAGONIST that has a serum t1/2 of 4 to 9 hrs and is administered orally or IV

A

Ondansetron, Granisetron, Dolasetron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SEROTONIN 5-HT3 ANTAGONIST that has greater affinity to the 5-HT3 receptor

A

Palonosteron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F: All SEROTONIN 5-HT3 ANTAGONIST
undergoes hepatic metabolism and are eliminated by
renal and hepatic excretion

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SEROTONIN 5-HT3 ANTAGONIST does not inhibit ___________

A

dopamine or muscarinic receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

blocks the 5-HT3 receptor found on the vomiting center
and on your chemoreceptor trigger zone

A

SEROTONIN 5-HT3 ANTAGONIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HISTAMINE ANTAGONISTs

A

Diphenhydramine, Dimenhydrinate
Meclizine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Weak antiemetic, particularly useful for prevention or
treatment of motion sickness

A

HISTAMINE ANTAGONIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1st generation H1 antagonist

A

Diphenhydramine, Dimenhydrinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

H1 antagonist that has significant anticholinergic properties

A

Diphenhydramine, Dimenhydrinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

H1 antagonist that may cause Sedation as its side effect

A

Diphenhydramine, Dimenhydrinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

H1 antihistamine agent with minimal anticholinergic
properties that also causes less sedation

A

Meclizine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

H1 antihistamine agent that is used to prevent motion sickness and the treatment of
vertigo due to labyrinth dysfunction

A

Meclizine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CORTICOSTEROIDs

A

Dexamethasone and Methylprednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Enhance the efficacy of 5-HT3 receptor antagonist for
prevention of acute and delayed nausea and vomiting

A

CORTICOSTEROID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

patient experiences N&V within 24 hrs after
taking chemotherapeutic agents

A

Acute nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

patient experiences
N&V after 24 hrs

A

Delayed nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Corticosteroid is usually used in an ______ form

A

IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Corticosteroid is useful in __________ regimen

A

cancer chemotherapeutic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

NEUROKININ RECEPTOR ANTAGONISTs

A

Aprepitant Fosaprepitant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NK1 receptor antagonist have __________ properties that
are mediated through central blockade in the area
_____________

A

antiemetic; postrema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
NK1 may also be given to patients that experiences
Cancer Induces Nausea and Vomiting (CINV)
26
Highly selective NK1 receptor antagonist that crosses the blood-brain barrier and occupies brain NK1 receptor found in CTZ
Aprepitant
27
NK1 receptor that has no affinity for serotonin and dopamine or corticosteroid receptor
Aprepitant
28
NK1 receptor that is associated with fatigue, dizziness and diarrhea
Aprepitant
29
Apprepritant is metabolized by ________ and may inhibit the metabolism of other drugs metabolized by ________
CYP3A4; CYP3A4
30
Aprepitant is available in
Oral form
31
Intravenous NK1 formulation that converted within 30 minutes after infusion to aprepitant (active form)
Fosaprepitant
32
MUSCARINIC ANTAGONISTs
Hyoscine / Scopolamine
33
Prototypic muscarinic receptor antagonist
Hyoscine / Scopolamine
34
Often used in preoperative analgesia, seasickness, motion sickness, ocular irritation and irritable bowel syndrome
Hyoscine / Scopolamine
35
Hyoscine / Scopolamine is used as an
antiemetic
36
Hyoscine / Scopolamine may produce very high incidence of anticholinergic effects when given _____ or ___________
orally or parenterally
37
DOPAMINE 2 BLOCKERs
Phenothiazine Droperidol
38
Antipsychotic agents that can be used for their potent antiemetic and sedative properties
Phenothiazine
39
Phenothiazine inhibits _______ and _________receptor
dopamine and muscarinic receptor
40
Phenothiazine's sedative properties are due to their
antihistamine activity
41
Phenothiazine drugs
Prochlorperazine, Promethazine, and Thiethylperazine
42
Antipsychotic butyrophenone also possess antiemetic properties due to their central dopaminergic blockade
Droperidol
43
Droperidol is given as
IM or IV
44
SUBSTITUTED BENZAMIDE
Metoclopramide and Trimethobenzamide
45
Primary mechanism of SUBSTITUTED BENZAMIDE' antiemetic action is believed to be ______________
dopamine receptor blockade
46
SUBSTITUTED BENZAMIDE that has weak antihistaminic activity, for prevention and treatment of nausea and vomiting
Trimethobenzamide
47
Principal adverse effect of these central dopamine antagonist are extrapyramidal
SUBSTITUTED BENZAMIDE
48
extrapyramidal ADE of SUBSTITUTED BENZAMIDE
restlessness, dystonia and parkinsonian symptoms
49
BENZODIAZEPINEs
Lorazepam and Diazepam
50
Used before the initiation of chemotherapy to reduce anticipatory vomiting or vomiting caused by anxiety
BENZODIAZEPINE
51
when patient previously had chemo and experienced N&V
Anticipatory vomiting:
52
CANNABINOIDS
Dronabinol, Nabilone
53
T/F: Cannabinoids as oral medications, is fairly effective
T
54
Almost completely absorbed but undergoes significant first-pass hepatic metabolism
CANNABINOIDS
55
Associated with an increase appetite
CANNABINOIDS
56
T/F: CANNABINOIDS is also used in in cancer chemotherapeutic regimen
T
57
T/F: CANNABINOIDS are More effective than marijuana
T
58
IBD comprise 2 distinct disorder: ___________ and ___________
ulcerative colitis and Crohn’s disease
59
AMINOSALICYLATES 5-ASA
Sulfazalazine, Olsalazine, Balsalazide and various forms of Mesalamine
60
AMINOSALICYLATES 5-ASA differs from salicylic acid only by the addition of an _____________ at the 5 (meta) position
amino group
61
AMINOSALICYLATES 5-ASA work topically in areas of ____________
diseased gastrointestinal mucosa
62
Aqueous 5-ASA is absorbed from the ______________ and (reaches/does not reach) the distal small bowel or colon in appreciable quantities
small intestine; does not reach
63
_____________is readily/rapidly absorbed from the small intestine, absorption of 5-ASA from the colon is _____________
Unformulated 5-ASA; extremely low
64
Absorbed 5-ASA undergoes _____________ in the gut epithelium and liver to a metabolite that does not possess significant anti-inflammatory activity
N-acetylation
65
GLUCOCORTICOIDs
Budesonide
66
inhibit production of inflammatory cytokines and chemokines to reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, Cyclooxygenase-2 and NF- KB
Glucocorticoids
67
Glucocorticoids inhibit production of inflammatory _________________ to reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of __________, __________, __________ and __________
cytokines and chemokines; nitric oxide synthase, phospholipase A2, Cyclooxygenase-2 and NF- KB
68
Potent synthetic analog of prednisolone
Budesonide
69
High affinity for glucocorticoid receptor but is subject to rapid first-pass hepatic metabolism
Budesonide
70
Widely used in transplantation medicine and autoimmune disease
AZATHIOPRINE, 6-MERCAPTOPURINE
71
Prodrug for mercaptopurine
AZATHIOPRINE
72
Moderately to severe Crohn’s disease or chronically active Crohn's disease
AZATHIOPRINE, 6-MERCAPTOPURINE
73
Associated with low risk of lymphoma causality uncertain
AZATHIOPRINE
74
Also used in children at lower doses
AZATHIOPRINE
75
Other uses include rheumatoid arthritis and systemic lupus erythematosus
AZATHIOPRINE
76
Interferes with nucleic acid synthesis, affecting B and T cell function
6-MERCAPTOPURINE
77
Antimetabolite and antifolate drug
METHOTREXATE
78
Interferes with nucleic acid synthesis, and the folic acid pathway
METHOTREXATE
79
Inhibits dihydrofolate reductase
METHOTREXATE
80
Underused in Crohn’s disease, but is essential for management of IBD.
METHOTREXATE
81
TUMOR NECROSIS FACTOR ANTAGONISTs
Infliximab, Adalimumab, Golimumab, and Certolizumab
82
TUMOR NECROSIS FACTOR ANTAGONIST binds _______ and _______ TNF with high affinity, preventing the cytokine from binding to its receptor
soluble; membrane-bound
83
Causes reverse signaling that suppresses cytokine release
TUMOR NECROSIS FACTOR ANTAGONIST
84
is a family of adhesion molecule on the surface of leukocytes that may interact with another class of adhesion molecules on the surface of the vascular endothelium known as selectins allowing circulating leukocytes to adhere to the vascular endothelium and subsequently move through the vessel wall into the tissue.
Integrin
85
Integrin is a family of __________ molecule on the surface of leukocytes that may interact with another class of adhesion molecules on the surface of the vascular endothelium known as ___________ allowing circulating leukocytes to adhere to the vascular endothelium and subsequently move through the vessel wall into the tissue
adhesion; selectins
86
ANTI-INTEGRIN THERAPY Drugs
Natalizumab
87
Blocks integrins on circulating leukocytes
Natalizumab
88
May be associated with multifocal leukoencephalopathy
Natalizumab
89
Restricted to patients with severe Crohn’s disease
Natalizumab
90
PANCREATIC REPLACEMENT THERAPY Drug
Natalizumab
91
Not producing sufficient amount of pancreatic enzyme
Exocrine pancreatic insufficiency
92
When secretion of pancreatic enzyme falls below 10% of normal, fat and protein digestion is impaired and can lead to __________
steatorrhea, azotorrrhea, vitamin malabsorption and weight loss
93
These product (from pigs) substitute for pancreatic lipase
Natalizumab
94
Natalizumab is inactivated at pH levels below _______
4.0
95
Natalizumab is taken as
enteric coated capsule
96
GALLSTONE PREVENTION Drugs
Ursodiol (Ursodeoxycholic acid)
97
Cholesterol stones are caused by the ___________ of cholesterol out of solution in the bile
precipitation
98
Ursodiol decrease cholesterol content of bile by
○ Decreasing cholesterol uptake by the intestine ○ Breaking up micelles containing cholesterol ● Decreasing hepatic cholesterol secretion
99
Also used to relieve itching in pregnancy caused by obstetric cholestasis
Ursodiol (Ursodeoxycholic acid)
100
DRUGS USED TO TREAT VARICEAL HEMORRHAGE
Somatostatin and Octreotide Vasopressin, Terlipressin
101
Portal hypertension most commonly occur as a consequence of chronic liver disease
VARICEAL HEMORRHAGE
102
Agents that cause constriction so that the bleeding in the variceal blood vessels would be inhibited.
Somatostatin and Octreotide
103
Antidiuretic hormone secreted by the hypothalamus
Vasopressin
104
Potent arterial vasoconstrictor
Vasopressin
105
Vasopressin analog
Terlipressin
106
Drugs that can be used in Cancer Chemotherapy
SEROTONIN 5-HT3 ANTAGONIST (Ondansetron, Granisetron, Dolasetron, Palonosteron) CORTICOSTEROID (Dexamethasone and Methylprednisolone) NEUROKININ RECEPTOR ANTAGONIST (Aprepitant, Fosaprepitant) CANNABINOIDS (Dronabinol, Nabilone)